Occupational Pharmaceutical Counterfeiting Schemes: A Crime Scripts Analysis

ABSTRACT This article presents a crime script for pharmaceutical counterfeiting schemes perpetrated by licensed health care professionals; we term these types of schemes occupational pharmaceutical counterfeiting. To date, there have been no empirical investigations of these schemes, nor any attempts to disentangle their many elements and components. Using qualitative content analysis techniques we examined data from the A-CAPP Product Counterfeiting database related to pharmaceutical counterfeiting schemes. We develop a crime script for pharmaceutical counterfeiting that describes key acts, scenes, actors, activities, and enforcement conditions. Occupational counterfeiters leverage their position as a health care provider to abuse patient trust and conceal their deviant acts.

[1]  C. Bova,et al.  Measuring patient-provider trust in a primary care population: refinement of the health care relationship trust scale. , 2012, Research in nursing & health.

[2]  A. Strauss,et al.  The discovery of grounded theory: strategies for qualitative research aldine de gruyter , 1968 .

[3]  P. Tremblay,et al.  Body Switching and Related Adaptations in the Resale of Stolen Vehicles. Script Elaborations and Aggregate Crime Learning Curves , 2001 .

[4]  Erick C. Jones,et al.  RFID Implementation and Enterprise Management in the Healthcare Sector , 2015 .

[5]  C. Catizone Counterfeit Drugs and States’ Efforts to Combat the Problem , 2006 .

[6]  Jeremy M. Wilson,et al.  Who are the guardians in product counterfeiting? A theoretical application of routine activities theory , 2014 .

[7]  Sandra L. Rierson Pharmaceutical Counterfeiting and the Puzzle of Remedies , 2008 .

[8]  M. Chin,et al.  Patient Trust in Physicians and Shared Decision-Making Among African-Americans With Diabetes , 2013, Health communication.

[9]  Anil K Deisingh,et al.  Pharmaceutical counterfeiting. , 2005, The Analyst.

[10]  Matthew B. Miles,et al.  Qualitative Data Analysis: An Expanded Sourcebook , 1994 .

[11]  A. Attaran,et al.  Why and How to Make an International Crime of Medicine Counterfeiting , 2011 .

[12]  Johnny Saldaña,et al.  Fundamentals of Qualitative Research , 2011 .

[13]  R. Clarke,et al.  Modeling Offenders' Decisions: A Framework for Research and Policy , 1985, Crime and Justice.

[14]  Leonard N. Reid,et al.  A Model of Consumer Response to Over-the-Counter Drug Advertising: Antecedents and Influencing Factors , 2016, Journal of health communication.

[15]  A. Lavorgna The online trade in counterfeit pharmaceuticals: New criminal opportunities, trends and challenges , 2015 .

[16]  C. Bennett,et al.  Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States. , 2012, Journal of oncology practice.

[17]  M. Yar The Other Global Drugs Crisis: Assessing the Scope, Impacts and Drivers of the Trade in Dangerous Counterfeit Pharmaceuticals , 2008 .

[18]  S. Chainey,et al.  Profiling Illegal Waste Activity: Using Crime Scripts as a Data Collection and Analytical Strategy , 2011 .

[19]  Counterfeit medicines: the silent epidemic. , 2006, Indian journal of medical sciences.

[20]  Hervé Borrion Quality assurance in crime scripting , 2013 .

[21]  L. Valvo,et al.  Development and validation of a reversed-phase LC method for analysing potentially counterfeit antimalarial medicines. , 2006, Journal of pharmaceutical and biomedical analysis.

[22]  G. Laycock,et al.  The Value of Crime Scripting: Deconstructing Internal Child Sex Trafficking , 2011 .

[23]  Eric Beauregard,et al.  Script Analysis of the Hunting Process of Serial Sex Offenders , 2007 .

[24]  Paul N. Newton,et al.  The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers , 2005, PLoS Medicine.

[25]  H. Zucker,et al.  Innovations to Address Global Drug Counterfeiting: Implications for Urbanization and Health , 2015 .

[26]  P. Newton,et al.  Impact of poor-quality medicines in the ‘developing’ world , 2010, Trends in pharmacological sciences.

[27]  Deborah E. Jones,et al.  Patient trust in physicians and adoption of lifestyle behaviors to control high blood pressure. , 2012, Patient education and counseling.

[28]  N. Ford,et al.  Substandard medicines in resource‐poor settings: a problem that can no longer be ignored , 2008, Tropical medicine & international health : TM & IH.

[29]  Matthew E Falagas,et al.  Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. , 2007, The Journal of antimicrobial chemotherapy.

[30]  Michael A. Veronin,et al.  Magic Bullet Gone Astray: Medications and the Internet , 2004, Science.

[31]  A. Michael Huberman,et al.  An expanded sourcebook qualitative data analysis , 1994 .

[32]  S. H. Choi,et al.  RFID tag data processing in manufacturing for track-and-trace anti-counterfeiting , 2015, Comput. Ind..

[33]  M. Forzley Counterfeit Goods and the Public's Health and Safety , 2003 .

[34]  Justin A. Heinonen,et al.  Product counterfeiting at the state level: An empirical examination of Michigan-related incidents , 2012 .

[35]  R. Dinarvand,et al.  Counterfeit medicines: report of a cross-sectional retrospective study in Iran. , 2011, Public health.

[36]  D. Cornish THE PROCEDURAL ANALYSIS OF OFFENDING AND ITS RELEVANCE FOR SITUATIONAL PREVENTION , 1994 .